Documents & Downloads

CDK2-IN-21

CDK2 Inhibitor

CDK2-IN-21 is a selective inhibitor of cyclin-dependent kinase 2 (CDK2) with an IC50 of 0.24 µM. This compound demonstrates potent inhibitory activity, making it a valuable tool for cancer research. By targeting CDK2, CDK2-IN-21 can help elucidate the role of cell cycle regulation in tumorigenesis and facilitate the development of potential therapeutic strategies against cancer.

Out of Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Specifications

Manufacturer	Adooq Bioscience
Actions	Inhibitor
CAS Number	2991229-06-0
Applications	CDK2 Inhibitor
Formula	C₃₃H₂₉F₈N₅O₄S₃
Molecular Weight	807.80
SMILES	FC(F)(C12CC(C2)(C3=NC(C4=C(C(NS(=O)(C5=C(C=CC=C5F)C(F)(F)F)=O)=CC=C4)F)=C(C6=NC(N[C@@H]7CC[C@H](CC7)S(C)(=O)=O)=NC=C6)S3)C1)F

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.